Skip to main content

CORRECTION article

Front. Endocrinol., 15 November 2024
Sec. Thyroid Endocrinology
Volume 15 - 2024 | https://doi.org/10.3389/fendo.2024.1517690

Corrigendum: Surgical outcome and malignant risk factors in patients with thyroid nodule classified as Bethesda category III

This article is a correction to:

  1. Surgical Outcome and Malignant Risk Factors in Patients With Thyroid Nodule Classified as Bethesda Category III

    1. Read original article
Jianhao Huang,&#x;Jianhao Huang1,2†Hongyan Shi,&#x;Hongyan Shi1,3†Muye Song,&#x;Muye Song1,4†Jinan Liang,Jinan Liang1,3Zhiyuan Zhang,Zhiyuan Zhang1,3Xiaohang Chen,Xiaohang Chen1,2Yongchen LiuYongchen Liu1Sanming WangSanming Wang1Zeyu Wu*Zeyu Wu1*
  • 1Department of General Surgery, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China
  • 2Shantou University Medical College, Shantou, China
  • 3The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China
  • 4School of Medicine, South China University of Technology, Guangzhou, China

A Corrigendum on
Surgical outcome and malignant risk factors in patients with thyroid nodule classified as Bethesda category III

By Huang J, Shi H, Song M, Liang J, Zhang Z, Chen X, Liu Y, Wang S and Wu Z (2021) Front. Endocrinol. 12:686849. doi: 10.3389/fendo.2021.686849

In the published article, there was an error in the Funding statement. The Funding statement for the Guangdong Basic and Applied Basic Research Foundation was displayed as “Natural Science Foundation of Guangdong Province (No. 2020A1515010127)”. The correct statement is “Guangdong Basic and Applied Basic Research Foundation (No. 2020A1515010126)”. The correct Funding statement appears below.

“This work was supported by Guangdong Basic and Applied Basic Research Foundation (No. 2020A1515010126), Scientific Research Staring Foundation for the Returned Overseas from Guangdong Provincial People’s Hospital (No. 2017x02) and Guangdong Provincial People’s Hospital Scientific Foundation for Distinguished Young Scholars of Guangdong Province (No. KJ012019441).”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: thyroid cancer, autoimmune thyroid antibodies, tumor size, fine needle aspirate (FNA), microcalcification

Citation: Huang J, Shi H, Song M, Liang J, Zhang Z, Chen X, Liu Y, Wang S and Wu Z (2024) Corrigendum: Surgical outcome and malignant risk factors in patients with thyroid nodule classified as Bethesda category III. Front. Endocrinol. 15:1517690. doi: 10.3389/fendo.2024.1517690

Received: 26 October 2024; Accepted: 31 October 2024;
Published: 15 November 2024.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2024 Huang, Shi, Song, Liang, Zhang, Chen, Liu, Wang and Wu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Zeyu Wu, wu.zeyu@hotmail.com

†These authors have contributed equally to this work and share first authorship

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.